Developer docs
API playgroundTry for free, no card

Search company profiles

Clayton, Dubilier & Rice, LLC

Full company profile

uuid005nzd3

Namestring
Clayton, Dubilier & Rice, LLC
Legal namestring
Clayton, Dubilier & Rice, LLC
Websiteurl
cdr.com
Company typeenum
Private
Founded yearint
1978
Descriptiontext

Clayton, Dubilier & Rice, LLC (CD&R) is a privately held global private equity firm founded in 1978 by Gene Clayton, Marty Dubilier, and Joe Rice, with principal operations in New York (550 Madison Avenue) and London (Cleveland House). The firm invests across industrial, healthcare, consumer, technology, and financial services sectors, sourcing large-scale control and platform transactions through deep operating expertise and partnerships with management teams. Recent marquee transactions include the $10.3B acquisition of Sealed Air (2026), the $8.9B joint acquisition of R1 RCM with TowerBrook (2024), and the $8.8B divestiture of Foundation Building Materials to Lowe's (2025). The firm also co-controls private platforms such as Truist Insurance Holdings (with Stone Point), Mosaic Health (with Elevance Health), Exclusive Networks (with Everest), and agilon health, alongside an India-focused joint venture with Kedaara Capital.

CD&R generates revenue through managing private equity funds, earning management fees on committed capital from a global limited partner base — university endowments, foundations, public and corporate pension funds, sovereign wealth funds, financial institutions, and family offices — plus carried interest on realized investment gains. Fund interests are placed privately via confidential private placement memoranda, and the firm maintains FCA-regulated, MIFIDPRU-compliant UK operations through CD&R LLP (England & Wales, registration OC343911). Distribution is direct and institution-only; there is no traditional product surface or public pricing.

The firm employs approximately 324 people across its U.S. and U.K. offices (229 North America, 95 Europe), led by CEO Nate Sleeper (since joining in 2000), Chairman Donald J. Gogel, Co-President David A. Novak, CFO Jillian C. Griffiths, and Founder Joseph L. Rice III. CD&R has been recognized on the Inc. Founder-Friendly Investors list and GrowthCap's Top Private Equity Firm rankings each year from 2023 through 2025. In May 2026 the firm formally expanded a Tech Value Creation function under Partner Stephen Shapiro, with Managing Director Chris Satchell as Head of Portfolio Technology, signaling deeper technology-enabled operating capability across the portfolio.

Short descriptiontext

CD&R is a privately held global private equity firm founded in 1978, managing funds for institutional LPs and executing large-scale control investments across industrial, healthcare, consumer, technology, and financial services sectors through offices in New York and London.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
private equity, private equity fund management, operational value creation, institutional investment management, large-cap buyout
NAICS code1 code
  • Funds, Trusts, and Other Financial Vehicles525
Product category
Private Equity
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Private Equity Fund Management
TypeManaged Services
Description

CD&R generates revenue through managing private equity funds, typically earning management fees on committed capital and performance fees (carried interest) based on investment returns to limited partners.

cdr.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

CD&R is a private equity investment firm that raises capital from institutional investors and deploys it into portfolio companies across industrial, healthcare, consumer, technology, and financial services sectors. The firm partners with management teams to drive operational value creation, strategic direction, and long-term sustainable growth, and earns revenue through management fees on committed capital and performance-based carried interest.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

CD&R is a private equity investment firm that does not offer a traditional product in the SaaS sense. The firm provides private equity investment services, working with management teams to build businesses and generate long-term value. The firm's activities include investment management, portfolio company stewardship, and operational value creation. No discrete commercial software products or modules are offered for external sale.

Product and service3 records
1Private Equity Fund Management
CategoryPrivate Equity Investment Management
Description

End-to-end private equity fund management service for global institutional limited partners, including capital raising, investment sourcing, due diligence, transaction execution, portfolio company stewardship, operational value creation, and exit realization across industrial, healthcare, consumer, technology, and financial services sectors.

2Tech Value Creation Advisory
CategoryPortfolio Operations Support
Description

In-house technology advisory capability that supports CD&R portfolio companies with technology strategy, digital transformation, and technology-enabled value creation initiatives.

3FCA-Regulated UK Investment Advisory
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint venture in India; Kevin A. Smith helped establish and plays a significant continuing role with the Firm's joint venture in India, Kedaara Capital.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with Sanofi for Opella consumer healthcare company; CD&R and Sanofi partnered to fuel Opella's ambitions in consumer healthcare and closed the transaction to create a global consumer healthcare leader.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

CVC joined CD&R as an investment partner in Epicor; CVC and CD&R closed transaction for strategic investment in Epicor.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership to advance primary care delivery; Elevance Health and Clayton, Dubilier & Rice signed agreement to launch strategic partnership to advance primary care delivery through Mosaic Health.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Blackstone is the world's largest alternative asset manager, with large-cap PE operations across multiple sectors. Directly comparable in mega-deal execution and global LP relationships.

TypeDirect peer
Description

TowerBrook is a PE firm focused on large-cap transactions across financial services, healthcare, and consumer. Co-invested with CD&R on R1 RCM ($8.9B), demonstrating direct transaction overlap.

TypeDirect peer
Description

Stone Point Capital is a PE firm focused on financial services. Co-invested with CD&R on Truist Insurance Holdings, evidencing direct collaboration on large-cap transactions.

TypeDirect peer
Description

CVC is a leading European PE firm executing large-cap buyouts globally, with deep European institutional LP base. CD&R and CVC have partnered on Epicor, demonstrating direct co-investment overlap.

TypeDirect peer
Description

Warburg Pincus is a global growth-oriented PE firm investing across healthcare, technology, consumer, and financial services. Comparable in scale and operating-partner approach.

TypeDirect peer
Description

TPG is a publicly-listed PE firm executing large-cap buyouts and growth investments across healthcare, technology, consumer, and financial services. Comparable in fund scale and operational focus.

TypeDirect peer
Description

Carlyle is a global PE firm executing large buyouts across industrial, healthcare, consumer, financial services, and technology. Highly comparable to CD&R in fund size, sector coverage, and approach to operational value creation.

TypeDirect peer
Description

Apollo is a publicly-listed alternative asset manager with large-cap PE strategies across industrial, healthcare, consumer, and financial services. Directly comparable in deal size and LP base.

TypeDirect peer
Description

KKR is one of the world's largest publicly-listed PE firms, executing large-cap buyouts and operational value creation across industrial, healthcare, consumer, and technology. Directly comparable to CD&R in target deal size, LP base, and sector coverage.

TypeDirect peer
Description

Bain Capital is a private, global PE firm with multi-strategy operations across industrial, healthcare, consumer, and technology. Highly comparable in deal size and operational value-creation focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Clayton, Dubilier & Rice, LLC

Private Equitycdr.com

CD&R is a privately held global private equity firm founded in 1978, managing funds for institutional LPs and executing large-scale control investments across industrial, healthcare, consumer, technology, and financial services sectors through offices in New York and London.

What Clayton, Dubilier & Rice, LLC does

Clayton, Dubilier & Rice, LLC (CD&R) is a privately held global private equity firm founded in 1978 by Gene Clayton, Marty Dubilier, and Joe Rice, with principal operations in New York (550 Madison Avenue) and London (Cleveland House). The firm invests across industrial, healthcare, consumer, technology, and financial services sectors, sourcing large-scale control and platform transactions through deep operating expertise and partnerships with management teams. Recent marquee transactions include the $10.3B acquisition of Sealed Air (2026), the $8.9B joint acquisition of R1 RCM with TowerBrook (2024), and the $8.8B divestiture of Foundation Building Materials to Lowe's (2025). The firm also co-controls private platforms such as Truist Insurance Holdings (with Stone Point), Mosaic Health (with Elevance Health), Exclusive Networks (with Everest), and agilon health, alongside an India-focused joint venture with Kedaara Capital.

CD&R generates revenue through managing private equity funds, earning management fees on committed capital from a global limited partner base — university endowments, foundations, public and corporate pension funds, sovereign wealth funds, financial institutions, and family offices — plus carried interest on realized investment gains. Fund interests are placed privately via confidential private placement memoranda, and the firm maintains FCA-regulated, MIFIDPRU-compliant UK operations through CD&R LLP (England & Wales, registration OC343911). Distribution is direct and institution-only; there is no traditional product surface or public pricing.

The firm employs approximately 324 people across its U.S. and U.K. offices (229 North America, 95 Europe), led by CEO Nate Sleeper (since joining in 2000), Chairman Donald J. Gogel, Co-President David A. Novak, CFO Jillian C. Griffiths, and Founder Joseph L. Rice III. CD&R has been recognized on the Inc. Founder-Friendly Investors list and GrowthCap's Top Private Equity Firm rankings each year from 2023 through 2025. In May 2026 the firm formally expanded a Tech Value Creation function under Partner Stephen Shapiro, with Managing Director Chris Satchell as Head of Portfolio Technology, signaling deeper technology-enabled operating capability across the portfolio.

Clayton, Dubilier & Rice, LLC firmographics

Firmographics
Name
Clayton, Dubilier & Rice, LLC
Legal name
Clayton, Dubilier & Rice, LLC
Website
https://cdr.com
Company type
Private
Founded year
1978
Operating status
Operating
Short description
CD&R is a privately held global private equity firm founded in 1978, managing funds for institutional LPs and executing large-scale control investments across industrial, healthcare, consumer, technology, and financial services sectors through offices in New York and London.
Ownership category
akta.pro rank

Where Clayton, Dubilier & Rice, LLC is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Clayton, Dubilier & Rice, LLC business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

  1. Private Equity Fund Management: CD&R generates revenue through managing private equity funds, typically earning management fees on committed capital and performance fees (carried interest) based on investment returns to limited partners.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Clayton, Dubilier & Rice, LLC product offering

Product offering

Core offering

CD&R is a private equity investment firm that raises capital from institutional investors and deploys it into portfolio companies across industrial, healthcare, consumer, technology, and financial services sectors. The firm partners with management teams to drive operational value creation, strategic direction, and long-term sustainable growth, and earns revenue through management fees on committed capital and performance-based carried interest.

Product overview

CD&R is a private equity investment firm that does not offer a traditional product in the SaaS sense. The firm provides private equity investment services, working with management teams to build businesses and generate long-term value. The firm's activities include investment management, portfolio company stewardship, and operational value creation. No discrete commercial software products or modules are offered for external sale.

Differentiator

Problem solved

Functional benefit

Products and services

  • Private Equity Fund Management End-to-end private equity fund management service for global institutional limited partners, including capital raising, investment sourcing, due diligence, transaction execution, portfolio company stewardship, operational value creation, and exit realization across industrial, healthcare, consumer, technology, and financial services sectors.
  • Tech Value Creation Advisory In-house technology advisory capability that supports CD&R portfolio companies with technology strategy, digital transformation, and technology-enabled value creation initiatives.
  • FCA-Regulated UK Investment Advisory

Companies that use Clayton, Dubilier & Rice, LLC

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles2 records

Clayton, Dubilier & Rice, LLC technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Clayton, Dubilier & Rice, LLC partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • Kedaara CapitalcoreStrategic or Co-development PartnerJoint venture in India; Kevin A. Smith helped establish and plays a significant continuing role with the Firm's joint venture in India, Kedaara Capital.
  • SanoficoreStrategic or Co-development PartnerPartnership with Sanofi for Opella consumer healthcare company; CD&R and Sanofi partnered to fuel Opella's ambitions in consumer healthcare and closed the transaction to create a global consumer healthcare leader.
  • CVC Capital PartnerscoreStrategic or Co-development PartnerCVC joined CD&R as an investment partner in Epicor; CVC and CD&R closed transaction for strategic investment in Epicor.
  • Elevance HealthcoreStrategic or Co-development PartnerStrategic partnership to advance primary care delivery; Elevance Health and Clayton, Dubilier & Rice signed agreement to launch strategic partnership to advance primary care delivery through Mosaic Health.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Clayton, Dubilier & Rice, LLC competitors and assessment

Company assessment

Direct peers

  • Blackstone Inc. Blackstone is the world's largest alternative asset manager, with large-cap PE operations across multiple sectors. Directly comparable in mega-deal execution and global LP relationships.
  • TowerBrook Capital Partners: TowerBrook is a PE firm focused on large-cap transactions across financial services, healthcare, and consumer. Co-invested with CD&R on R1 RCM ($8.9B), demonstrating direct transaction overlap.
  • Stone Point Capital: Stone Point Capital is a PE firm focused on financial services. Co-invested with CD&R on Truist Insurance Holdings, evidencing direct collaboration on large-cap transactions.
  • CVC Capital Partners: CVC is a leading European PE firm executing large-cap buyouts globally, with deep European institutional LP base. CD&R and CVC have partnered on Epicor, demonstrating direct co-investment overlap.
  • Warburg Pincus: Warburg Pincus is a global growth-oriented PE firm investing across healthcare, technology, consumer, and financial services. Comparable in scale and operating-partner approach.
  • TPG Inc. TPG is a publicly-listed PE firm executing large-cap buyouts and growth investments across healthcare, technology, consumer, and financial services. Comparable in fund scale and operational focus.
  • The Carlyle Group: Carlyle is a global PE firm executing large buyouts across industrial, healthcare, consumer, financial services, and technology. Highly comparable to CD&R in fund size, sector coverage, and approach to operational value creation.
  • Apollo Global Management: Apollo is a publicly-listed alternative asset manager with large-cap PE strategies across industrial, healthcare, consumer, and financial services. Directly comparable in deal size and LP base.
  • KKR & Co. Inc. KKR is one of the world's largest publicly-listed PE firms, executing large-cap buyouts and operational value creation across industrial, healthcare, consumer, and technology. Directly comparable to CD&R in target deal size, LP base, and sector coverage.
  • Bain Capital: Bain Capital is a private, global PE firm with multi-strategy operations across industrial, healthcare, consumer, and technology. Highly comparable in deal size and operational value-creation focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Clayton, Dubilier & Rice, LLC social profiles

Digital presence

Clayton, Dubilier & Rice, LLC compliance and trust

Trust signal

Compliance7 records

Clayton, Dubilier & Rice, LLC financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Clayton, Dubilier & Rice, LLC leadership team

Management profile

Number of profiles

Profiles7 records

Clayton, Dubilier & Rice, LLC funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Clayton, Dubilier & Rice, LLC M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clayton, Dubilier & Rice, LLC

What does Clayton, Dubilier & Rice, LLC do?

CD&R is a private equity investment firm that raises capital from institutional investors and deploys it into portfolio companies across industrial, healthcare, consumer, technology, and financial services sectors. The firm partners with management teams to drive operational value creation, strategic direction, and long-term sustainable growth, and earns revenue through management fees on committed capital and performance-based carried interest.

Is Clayton, Dubilier & Rice, LLC a public or private company?

Clayton, Dubilier & Rice, LLC is a private company. It is classified as management employee owned and is currently operating.

When was Clayton, Dubilier & Rice, LLC founded?

Clayton, Dubilier & Rice, LLC was founded in 1978.

Where is Clayton, Dubilier & Rice, LLC based?

Clayton, Dubilier & Rice, LLC is headquartered in New York, United States, in the North America region.

How does Clayton, Dubilier & Rice, LLC make money?

One revenue line is on record: private Equity Fund Management.

Who are Clayton, Dubilier & Rice, LLC's main competitors?

Direct peers on record are Blackstone Inc., TowerBrook Capital Partners, Stone Point Capital, CVC Capital Partners, Warburg Pincus, TPG Inc., The Carlyle Group, Apollo Global Management, KKR & Co. Inc. and Bain Capital.

Does Clayton, Dubilier & Rice, LLC have an API?

No public API is recorded for Clayton, Dubilier & Rice, LLC.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AdvisorhubApollo Agrees Deal to Invest in Wealth Network Focus FinancialApollo Global Management is investing $2.5 billion in Focus Financial Partners, valuing the wealth-management firm at about $21 billion including debt. Clayton Dubilier & Rice and Stone Point Capital remain controlling shareholders. Focus has over $550 billion in advised billable assets.Dealroom.coCD&R gathers $20B toward $26B flagship buyout fund | Dealroom NewsClayton, Dubilier & Rice raised about $20 billion for its 13th flagship buyout fund, Fund XIII, within six months of launching. The fund targets $26 billion with a hard cap of $28.5 billion, twice the pace of its predecessor. It aims to close in the first quarter of 2027.StocktwitsGPN Stock On Track For Its Worst Day In About 19 Months As Private Equity Firms Reportedly Abandon Takeover TalksGlobal Payments shares fell about 12% after private equity firms Clayton Dubilier & Rice and GTCR walked away from take-private talks. The discussions stalled over deal-structuring difficulties, and the company's largest outside shareholder, GTCR, holds roughly 15% equity. The stock is on track for its worst day since April 2025.YahooGPN Stock On Track For Its Worst Day In About 19 Months As Private Equity Firms Reportedly Abandon Takeover TalksGlobal Payments shares fell about 12% after private equity firms Clayton Dubilier & Rice and GTCR walked away from takeover talks. The discussions stalled over deal-structuring difficulties, and the company reported flat revenue near $7.7 billion in 2024 and 2025.TradingViewGPN Stock On Track For Its Worst Day In About 19 Months As Private Equity Firms Reportedly Abandon Takeover TalksGlobal Payments shares fell about 12% after private equity firms Clayton Dubilier & Rice and GTCR walked away from takeover talks. The discussions stalled over deal-structuring difficulties, and the company's stock is on track for its worst day since April 2025. GTCR remains the largest outside shareholder with roughly 15% equity.Investing.comWhy is Global Payments stock plunging today?Global Payments stock plunged 10.6% to $89.64 after private equity firms Clayton, Dubilier & Rice and GTCR abandoned a leveraged buyout bid. The deal, valued at roughly $40 billion, collapsed due to financing difficulties from the company's substantial net debt and tougher lending conditions. The unwinding of the deal premium left the stock repriced toward its standalone outlook.BloombergWall Street Banks to Lead $3 Billion Debt Deal for CD&R PurchaseWall Street banks led a $3.1 billion financing for Clayton, Dubilier & Rice and McKesson's acquisition of Option Care Health. The three-part package includes leveraged loans, secured and unsecured bonds, with Goldman Sachs, Bank of America, and Barclays leading.Investing.comAshland earnings up next as bidders eye specialty chemicals makerAshland Inc. will report Q4 fiscal 2026 earnings Tuesday, with analysts expecting EPS of $1.28 on revenue of $502.4 million, a potential 25% sequential profit jump. The results come amid a strategic review with Clayton, Dubilier & Rice and Clariant bidding, and activist investor Ancora's board seats.YahooGPN's $40B Takeover Buzz: Can Private Equity Revive Its Growth?Private equity firm Clayton, Dubilier & Rice is exploring a potential takeover of Global Payments in partnership with GTCR, with an enterprise value of about $40 billion. Discussions remain preliminary, and the deal could rank among the largest leveraged buyouts in history. Competitors Fiserv and Block are also mentioned, with Block's Square gross payment volume rising 13% to $72.8 billion.PrivateequitywireCD&R raises $20bn towards $26bn flagship buyout fund targetClayton, Dubilier & Rice raised about $20bn for its Fund XIII in six months, toward a $26bn target. The fund has a $28.5bn cap and is expected to close in Q1 2027, potentially becoming one of the largest buyout vehicles ever raised.